SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES
11 references·12 citing·38 second hop
EVALUATING THE COST-EFFECTIVENESS OF CLINICAL AND PUBLIC HEALTH MEASURES (1998)EVALUATING THE COST-EFFECTIVENESS OF CLIN…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1997)Recommendations of the Panel …Recommendations of the Panel on Cost-effectiveness in Health and Medicine (1996)Recommendations of the Panel …Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Five‐Hundred Life‐Saving Inte…Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Declining value of alanine am…The Beaver Dam Health Outcomes study (1993)The Beaver Dam Health Outcome…Cost-effectiveness league tables: More harm than good? (1993)Cost-effectiveness league tab…Economic evaluation in health care: Is there a role for cost-benefit analysis? (1991)Economic evaluation in health…Cost Effectiveness of Prophylactic Intravenous Immune Globulin in Chronic Lymphocytic Leukemia (1991)Cost Effectiveness of Prophyl…Uncertainty (1990)UncertaintyFoundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Foundations of Cost-Effective…Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean? (2008)Economic Evaluations of Medic…Lessons from Cost-Effectiveness Research for United States Public Health Policy (2007)Lessons from Cost-Effectivene…Do we fully understand the economic value of vaccines? (2007)Do we fully understand the ec…The Costs and Benefits of Enhanced Depression Care to Employers (2006)The Costs and Benefits of Enh…Cost-effectiveness of Whole-Body CT Screening (2005)Cost-effectiveness of Whole-B…Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities (2005)Both clinical epidemiology an…When does quality‐adjusting life‐years matter in cost‐effectiveness analysis? (2004)When does quality‐adjusting l…Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments (2003)Variation in the Estimation o…Amplifying issues related to psychological testing and assessment. (2002)Amplifying issues related to …Cost-utility analyses of clinical preventive services (2000)Cost-utility analyses of clin…Cost-effectiveness of Functional Imaging Tests in the Diagnosis of Alzheimer Disease (2000)Cost-effectiveness of Functio…Cost and quality under managed care: irreconcilable differences? (2000)Cost and quality under manage…Measurement of health state utilities for economic appraisal (1986)Methods for the economic evaluation of health care programmes (1987)Users' Guides to the Medical Literature (1997)Health Policy in a Globalising World (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost Effectiveness in Low- and Middle-Income Countries (2009)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)One Thousand Health-Related Quality-of-Life Estimates (2000)Swedish population health-related quality of life results using the EQ-5D (2001)Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States (2006)Human Capital (1983)Willingness to pay for antihypertensive therapy — results of a Swedish pilot study (1991)Cost-benefit analysis. (1993)Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. (2003)Theory of games and economic behavior (2019)Whose Utilities for Decision Analysis? (1990)Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems (1993)The standard gamble method: what is being measured and how it is interpreted. (1994)Clinical decision analysis (2005)Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model (2007)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Trust, Emotion, Sex, Politics, and Science: Surveying the Risk‐Assessment Battlefield (1999)Willingness to Pay for a Quality-adjusted Life Year (2000)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Assessing the costs of healthcare technologies in clinical trials. (1999)On the economic foundations of CEA. Ladies and gentlemen, take your positions! (2000)Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure (2001)Utility approach to measuring health-related quality of life (1987)Recommendations for Reporting Cost-effectiveness Analyses (1996)Utility Valuations for Outcome States of Colorectal Cancer (1999)Medicare and Cost-Effectiveness Analysis (2005)Improving Decision Analyses: Parent Preferences (Utility Values) for Pediatric Health Outcomes (2009)Risk Perception and Communication Unplugged: Twenty Years of Process1 (1995)Identification and Review of Sensitivity Analysis Methods (2002)Eliciting Expert Knowledge in Conservation Science (2012)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,118 cited
  • 1990Uncertainty1,711 cited
  • 1995Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness1,318 cited
  • 1993The Beaver Dam Health Outcomes study734 cited
  • 1993Cost-effectiveness league tables: More harm than good?249 cited
  • 1996Recommendations of the Panel on Cost-effectiveness in Health and Medicine235 cited
  • 1991Economic evaluation in health care: Is there a role for cost-benefit analysis?207 cited
  • 1991Cost Effectiveness of Prophylactic Intravenous Immune Globulin in Chronic Lymphocytic Leukemia204 cited
  • 1997Recommendations of the Panel on Cost-Effectiveness in Health and Medicine191 cited
  • 1995Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study124 cited

Cited by

  • 2003Variation in the Estimation of Quality-adjusted Life-years by Different Preference-based Instruments146 cited
  • 2000Cost and quality under managed care: irreconcilable differences?129 cited
  • 2007Lessons from Cost-Effectiveness Research for United States Public Health Policy

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

124 cited
  • 2006The Costs and Benefits of Enhanced Depression Care to Employers119 cited
  • 2004When does quality‐adjusting life‐years matter in cost‐effectiveness analysis?114 cited
  • 2000Cost-utility analyses of clinical preventive services111 cited
  • 2005Cost-effectiveness of Whole-Body CT Screening108 cited
  • 2008Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?90 cited
  • 2007Do we fully understand the economic value of vaccines?79 cited
  • 2000Cost-effectiveness of Functional Imaging Tests in the Diagnosis of Alzheimer Disease74 cited
  • 2005Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities32 cited
  • 2002Amplifying issues related to psychological testing and assessment.9 cited